Most Recent

image: Opinion: Life as a Target

Opinion: Life as a Target

By | March 27, 2013

Attacks on my work aimed at undermining climate change science have turned me into a public figure. I have come to embrace that role.

33 Comments

image: New Down Syndrome Protein Found

New Down Syndrome Protein Found

By | March 26, 2013

Researchers identify a protein involved in the chromosomal disorder that could explain its characteristic learning deficits.

0 Comments

image: Congress Finishes Spending Bill

Congress Finishes Spending Bill

By | March 25, 2013

Federal science agencies get some relief from the harsh cuts to their 2013 budgets instituted by the recent sequester.

0 Comments

image: Disputes Over Text-Mining

Disputes Over Text-Mining

By | March 21, 2013

Computer programs that trawl research papers can reveal important large-scale patterns and facilitate further research, but publishers are wary.

2 Comments

image: Anthrax Vax Test OK for Kids

Anthrax Vax Test OK for Kids

By | March 19, 2013

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Gov’t Science and the Media

Gov’t Science and the Media

By | March 15, 2013

Federal research agencies, such as the NIH, EPA, and NSF, are improving communication between their scientists and journalists, but most can do better.

1 Comment

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS